Income Statement TELCON RF PHARMACEUTICAL. Inc.

Stocks

A200230

KR7200230001

Communications & Networking

End-of-day quote Korea S.E. 2026-10-02			5-day change	1st Jan Change
2,275.00 ^KRW	-0.66%		+4.12%	-75.19%

07-14	TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd.	CI
07-05	TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd.	CI

64f306aec0f19f44216e95.lSlUk_gVhx1NcpY2IKZV-MJkftvmiSaI54Iphb3XIMc.4X8zq5VWwFosBe53T5Uju5M2EJW5sXHiyspH1v-cc5_vZjuim2zSaggeog

Published financial data: TELCON RF PHARMACEUTICAL. INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	37.84B	27.83B	36.31B	37.87B	43.16B
Other Revenues, Total	-	-	-10	-	-
Total Revenues	37.84B	27.83B	36.31B	37.87B	43.16B
Cost of Goods Sold, Total	28.78B	22.27B	26.8B	27.63B	33.04B
Gross Profit	9.07B	5.56B	9.51B	10.24B	10.12B
Selling General & Admin Expenses, Total	6.95B	4.55B	4.48B	6.25B	5.98B
Provision for Bad Debts	1.8B	747M	252M	206M	-417M
R&D Expenses	1.64B	1.21B	733M	723M	699M
Depreciation & Amortization - (IS)	472M	468M	449M	466M	385M
Amortization of Goodwill and Intangible Assets - (IS)	2.6B	2.58B	2.56B	2.55B	2.5B
Other Operating Expenses	168M	68.03M	59.76M	113M	253M
Other Operating Expenses, Total	13.63B	9.63B	8.54B	10.31B	9.4B
Operating Income	-4.56B	-4.06B	965M	-70.55M	719M
Interest Expense, Total	-7.7B	-1.06B	-604M	-3.76B	-4.81B
Interest And Investment Income	45.48M	61.42M	205M	325M	682M
Net Interest Expenses	-7.66B	-1B	-399M	-3.43B	-4.13B
Income (Loss) On Equity Invest.	-13.2B	-17.87B	470M	-24.68B	-3.22B
Currency Exchange Gains (Loss)	832M	318M	119M	603M	-126M
Other Non Operating Income (Expenses)	77.32M	-1.98B	-838M	1.12B	2.34B
EBT, Excl. Unusual Items	-24.51B	-24.6B	317M	-26.47B	-4.42B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	4.63B	-13.15B	13.47B	1.28B	-5.82B
Gain (Loss) On Sale Of Assets	10.31M	34.38M	-14.8M	17.27M	-
Asset Writedown	-3.01B	-4.41B	-64.8M	-1.1B	-1.32B
Other Unusual Items	-	-	245M	-227M	130M
EBT, Incl. Unusual Items	-22.88B	-42.12B	13.95B	-26.5B	-11.43B
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-22.88B	-42.12B	13.95B	-26.5B	-11.43B
Earnings Of Discontinued Operations	-331M	-	-	-	-
Net Income to Company	-23.21B	-42.12B	13.95B	-26.5B	-11.43B
Minority Interest	109M	32.81M	-42.34M	180M	-24.35M
Net Income - (IS)	-23.1B	-42.08B	13.91B	-26.32B	-11.46B
Net Income to Common Incl Extra Items	-23.1B	-42.08B	13.91B	-26.32B	-11.46B
Net Income to Common Excl. Extra Items	-22.77B	-42.08B	13.91B	-26.32B	-11.46B
Per Share Items
Net EPS - Basic	-8.76K	-13.22K	4.15K	-7.42K	-2.39K
Basic EPS - Continuing Operations	-8.64K	-13.22K	4.15K	-7.42K	-2.39K
Basic Weighted Average Shares Outstanding	2.64M	3.18M	3.35M	3.55M	4.8M
Net EPS - Diluted	-8.76K	-13.23K	3.42K	-7.42K	-2.39K
Diluted EPS - Continuing Operations	-8.64K	-13.23K	3.42K	-7.42K	-2.39K
Diluted Weighted Average Shares Outstanding	2.64M	3.18M	4.49M	3.55M	4.8M
Normalized Basic EPS	-5.77K	-4.82K	46.54	-4.61K	-581.06
Normalized Diluted EPS	-5.77K	-4.82K	34.79	-4.61K	-581.06
Supplemental Items
EBITDA	-363M	218M	5.21B	4.44B	5.54B
EBITA	-1.96B	-1.48B	3.53B	2.48B	3.22B
EBIT	-4.56B	-4.06B	965M	-70.55M	719M
EBITDAR	-328M	240M	5.22B	4.45B	5.56B
Effective Tax Rate - (Ratio)	-	-	-	-	-
Normalized Net Income	-15.21B	-15.34B	156M	-16.36B	-2.79B
Supplemental Operating Expense Items
Advertising Expense	3.36M	45.18M	10.76M	35.06M	13.19M
Marketing Expenses	27.95M	9.6M	4.48M	2.95M	3.14M
Selling and Marketing Expenses	2.69B	902M	934M	2.05B	1.37B
General and Administrative Expenses	17.21M	17.35M	18.14M	18.49M	19.37M
Research And Development Expense From Footnotes	1.64B	1.21B	733M	723M	699M
Net Rental Expense, Total	34.92M	21.13M	15.3M	14.28M	15.32M
Imputed Operating Lease Interest Expense	29.83M	4.17M	2.56M	10.34M	13.12M
Imputed Operating Lease Depreciation	5.09M	16.96M	12.74M	3.94M	2.2M
Maintenance & Repair Expenses, Total	59.72M	101M	79.9M	72.17M	85.06M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	23.2B	9.73B	8.52B	3.31B	26.12B
Short Term Investments	-	-	2B	731M	-
Trading Asset Securities, Total	-	-	-	6B	6B
Total Cash And Short Term Investments	23.2B	9.73B	10.52B	10.04B	32.12B
Accounts Receivable, Total	9.48B	6.14B	8.99B	8.75B	8.1B
Other Receivables	224M	268M	178M	233M	870M
Notes Receivable	-	31.36M	7.05B	78.75M	8.08B
Total Receivables	9.7B	6.44B	16.22B	9.06B	17.05B
Inventory	4.3B	4.62B	5B	4.96B	5.12B
Prepaid Expenses	98.87M	73.74M	83.2M	223M	266M
Other Current Assets, Total	55.98M	2.26B	1.16B	1.74B	3.17B
Total Current Assets	37.36B	23.13B	32.99B	26.01B	57.73B
Gross Property Plant And Equipment	19.57B	19.58B	19.97B	24.45B	23.15B
Accumulated Depreciation	-10.25B	-11.54B	-11.5B	-13.27B	-13.28B
Net Property Plant And Equipment	9.32B	8.04B	8.47B	11.18B	9.88B
Long-term Investments	90.29B	63.37B	74.8B	94.89B	70.21B
Goodwill	0	0	0	0	0
Other Intangibles, Total	30.2B	23.88B	21.34B	18.74B	16.23B
Accounts Receivable Long-Term	-190	-	-	-	-
Loans Receivable Long-Term	-	33.98M	45.97M	70.42M	58.08M
Other Long-Term Assets, Total	865M	800M	2.77B	2.7B	2.55B
Total Assets	168B	119B	140B	154B	157B
Liabilities
Accounts Payable, Total	2.63B	2.67B	2.58B	2.82B	3.14B
Accrued Expenses, Total	902M	720M	698M	900M	1.17B
Short-term Borrowings	53.99B	28.85B	26.44B	54.66B	32.31B
Current Portion of Long-Term Debt	430	430	170	500	-260
Current Portion of Leases	644M	694M	577M	438M	528M
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	1.95B	1.39B	4.62B	10.9B	9.11B
Total Current Liabilities	60.11B	34.33B	34.92B	69.72B	46.26B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.3B	728M	403M	590M	1.43B
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	7.91M	62.77M	143M	143M	158M
Total Liabilities	61.42B	35.12B	35.47B	70.45B	47.85B
Common Stock, Total	9.99B	10.86B	11.6B	12.03B	68.52B
Additional Paid In Capital	216B	238B	244B	246B	229B
Retained Earnings	-126B	-168B	-154B	-180B	-192B
Treasury Stock	-	-	-	-56.04M	-56.04M
Comprehensive Income and Other	6.9B	3.2B	3.09B	5.34B	2.9B
Total Common Equity	107B	84.12B	104B	82.83B	109B
Minority Interest	27.59M	12.26M	485M	305M	317M
Total Equity	107B	84.14B	105B	83.13B	109B
Total Liabilities And Equity	168B	119B	140B	154B	157B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3M	3.26M	3.48M	3.61M	6.85M
ECS Total Common Shares Outstanding	3M	3.26M	3.48M	3.61M	6.85M
Book Value / Share	35.56K	25.82K	30.02K	22.96K	15.84K
Tangible Book Value	76.38B	60.24B	83.12B	64.09B	92.27B
Tangible Book Value Per Share	25.48K	18.49K	23.89K	17.77K	13.47K
Total Debt	55.94B	30.28B	27.42B	55.69B	34.27B
Net Debt	32.74B	20.54B	16.9B	45.65B	2.14B
Debt Equivalent Oper. Leases	279M	169M	122M	114M	123M
Minority Interest, Total (Incl. Fin. Div)	27.59M	12.26M	485M	305M	317M
Equity Method Investments, Total	60.58B	13.81B	13.44B	57.55B	-
Inventories - Raw Materials, Total	1.89B	3.27B	2.81B	3.3B	3.63B
Inventories - Work In Process, Total	732M	609M	1.53B	422M	402M
Inventories - Finished Goods, Total	2.37B	2.51B	2.11B	2.13B	2.69B
Inventories - Others	-160	-490	50	340	90
Land - (BS)	827M	827M	827M	827M	827M
Buildings, Total	4.87B	4.97B	5.08B	5.58B	5.41B
Machinery, Total	7.93B	8.02B	7.7B	10.72B	11.86B
Accumulated Allowance for Doubtful Accounts (Supple)	185M	931M	1.18B	1.39B	860M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	-23.1B	-42.08B	13.91B	-26.32B	-11.46B
Depreciation & Amortization - CF	1.6B	1.7B	1.68B	1.96B	2.32B
Amortization of Goodwill and Intangible Assets - (CF)	2.6B	2.58B	2.56B	2.55B	2.5B
Depreciation & Amortization, Total	4.2B	4.28B	4.24B	4.51B	4.82B
(Gain) Loss From Sale Of Asset	250M	-34.38M	14.8M	-17.27M	-487M
(Gain) Loss on Sale of Investments - (CF)	-4.63B	13.15B	-13.47B	-1.28B	5.82B
Asset Writedown & Restructuring Costs	3.01B	4.41B	64.8M	1.1B	1.32B
(Income) Loss On Equity Investments - (CF)	13.2B	17.87B	-470M	24.68B	3.71B
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-19.19M	747M	252M	206M	-417M
Other Operating Activities, Total	7.38B	2.65B	963M	619M	1.04B
Change In Accounts Receivable	-791M	-1.45B	-6.56B	-3.91B	-2.96B
Change In Inventories	-677M	-1.68B	-718M	529M	-1.12B
Change In Accounts Payable	60.21M	647M	503M	1.57B	1.14B
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	758M	-587M	133M	-475M	242M
Cash from Operations	-359M	-2.09B	-1.13B	1.22B	1.67B
Capital Expenditure	-2.25B	-819M	-3.82B	-4.97B	-320M
Sale of Property, Plant, and Equipment	60.24M	66.81M	5.88M	18.05M	-
Cash Acquisitions	-	-	-	-	-30.98M
Divestitures	-	-	-	-	506M
Sale (Purchase) of Intangible assets	-3.56B	-14.52M	-18M	-7.13M	-
Investment in Marketable and Equity Securities, Total	6.51B	-7.08B	419M	-44.54B	6.4B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-82.22M	-7.08B	5.37B	-8.1B
Other Investing Activities, Total	124M	46.34M	-32.32M	38.83M	194M
Cash from Investing	879M	-7.89B	-10.52B	-44.08B	-1.34B
Short Term Debt Issued, Total	-	200M	-	36.6B	2.8B
Long-Term Debt Issued, Total	-	1B	13.11B	29.78B	11.88B
Total Debt Issued	-	1.2B	13.11B	66.38B	14.68B
Short Term Debt Repaid, Total	-	-	-200M	-18B	-19.4B
Long-Term Debt Repaid, Total	-1.92B	-4.64B	-2.95B	-10.74B	-12.71B
Total Debt Repaid	-1.92B	-4.64B	-3.15B	-28.74B	-32.11B
Issuance of Common Stock	-	-	-	-	40.19B
Other Financing Activities, Total	31.01M	-	485M	8.55M	-253M
Cash from Financing	-1.89B	-3.44B	10.45B	37.65B	22.5B
Foreign Exchange Rate Adjustments	24.42M	-43.32M	-459K	600K	-7.65M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-1.35B	-13.46B	-1.21B	-5.21B	22.82B
Supplemental Items
Cash Interest Paid	2.42B	861M	554M	1.3B	2.06B
Cash Income Tax Paid (Refund)	40.1M	-27.4M	45.14M	200M	-214M
Levered Free Cash Flow	-7.72B	316M	-5.32B	10.35B	-8.89B
Unlevered Free Cash Flow	-2.9B	980M	-4.94B	12.7B	-5.88B
Change In Net Working Capital	-1.56B	-72.07M	5.95B	-13.21B	10.83B
Net Debt Issued / Repaid	-1.92B	-3.44B	9.96B	37.64B	-17.43B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	-1.62	-1.77	0.46	-0.03	0.29
Return on Total Capital	-1.67	-1.83	0.49	-0.03	0.32
Return On Equity %	-23.1	-44.16	14.75	-28.18	-11.91
Return on Common Equity	-23.01	-44.14	14.75	-28.11	-11.97
Margin Analysis
Gross Profit Margin %	23.96	19.99	26.19	27.03	23.45
SG&A Margin	18.37	16.36	12.35	16.51	13.85
EBITDA Margin %	-0.96	0.78	14.35	11.72	12.84
EBITA Margin %	-5.18	-5.32	9.72	6.54	7.47
EBIT Margin %	-12.06	-14.6	2.66	-0.19	1.66
Income From Continuing Operations Margin %	-60.45	-151.34	38.42	-69.98	-26.48
Net Income Margin %	-61.04	-151.22	38.3	-69.51	-26.54
Net Avail. For Common Margin %	-60.16	-151.22	38.3	-69.51	-26.54
Normalized Net Income Margin	-40.19	-55.12	0.43	-43.21	-6.46
Levered Free Cash Flow Margin	-20.39	1.14	-14.66	27.33	-20.59
Unlevered Free Cash Flow Margin	-7.67	3.52	-13.62	33.54	-13.62
Asset Turnover
Asset Turnover	0.21	0.19	0.28	0.26	0.28
Fixed Assets Turnover	4.27	3.21	4.4	3.85	4.1
Receivables Turnover (Average Receivables)	4.2	3.56	4.8	4.27	5.13
Inventory Turnover (Average Inventory)	6.71	4.99	5.57	5.55	6.56
Short Term Liquidity
Current Ratio	0.62	0.67	0.94	0.37	1.25
Quick Ratio	0.55	0.47	0.56	0.27	0.89
Operating Cash Flow to Current Liabilities	-0.01	-0.06	-0.03	0.02	0.04
Days Sales Outstanding (Average Receivables)	86.95	102.42	76.05	85.73	71.19
Days Outstanding Inventory (Average Inventory)	54.41	73.16	65.55	65.97	55.67
Average Days Payable Outstanding	33.38	42.8	35.24	35.82	32.75
Cash Conversion Cycle (Average Days)	107.98	132.77	106.36	115.87	94.11
Long Term Solvency
Total Debt/Equity	52.47	35.98	26.13	66.99	31.49
Total Debt / Total Capital	34.41	26.46	20.72	40.12	23.95
LT Debt/Equity	1.22	0.86	0.38	0.71	1.32
Long-Term Debt / Total Capital	0.8	0.64	0.3	0.42	1
Total Liabilities / Total Assets	36.55	29.45	25.26	45.87	30.54
EBIT / Interest Expense	-0.59	-3.82	1.6	-0.02	0.15
EBITDA / Interest Expense	-0.05	0.21	8.63	1.18	1.15
(EBITDA - Capex) / Interest Expense	-0.34	-0.57	2.3	-0.14	1.09
Total Debt / EBITDA	-154.06	138.58	5.26	12.55	6.18
Net Debt / EBITDA	-90.18	94.02	3.24	10.29	0.39
Total Debt / (EBITDA - Capex)	-21.37	-50.38	19.73	-104.75	6.56
Net Debt / (EBITDA - Capex)	-12.51	-34.18	12.16	-85.87	0.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.18	-26.46	30.46	4.29	13.99
Gross Profit, 1 Yr. Growth %	25.28	-38.61	70.9	7.67	-1.15
EBITDA, 1 Yr. Growth %	-115.74	-160.17	2.28K	-14.85	24.94
EBITA, 1 Yr. Growth %	-474.04	-24.48	-338.38	-29.82	30.06
EBIT, 1 Yr. Growth %	118.34	-10.96	-123.76	-107.31	-1.12K
Earnings From Cont. Operations, 1 Yr. Growth %	-45.1	84.12	-133.12	-289.98	-56.86
Net Income, 1 Yr. Growth %	-43.52	82.2	-133.04	-289.26	-56.48
Normalized Net Income, 1 Yr. Growth %	-42.38	0.86	-101.02	-10.58K	-82.97
Diluted EPS Before Extra, 1 Yr. Growth %	-45.33	53.19	-125.84	-317.05	-67.79
Accounts Receivable, 1 Yr. Growth %	10.87	-35.23	46.45	-2.7	-7.31
Inventory, 1 Yr. Growth %	0.63	7.41	8.24	-0.95	3.38
Net Property, Plant and Equip., 1 Yr. Growth %	10.73	-13.75	5.35	32.02	-11.66
Total Assets, 1 Yr. Growth %	-9.2	-29.03	17.74	9.38	2.01
Tangible Book Value, 1 Yr. Growth %	29.05	-21.13	37.98	-22.89	43.96
Common Equity, 1 Yr. Growth %	16.69	-21.07	24.17	-20.71	30.99
Cash From Operations, 1 Yr. Growth %	-112.79	483.69	-45.78	-207.42	36.73
Capital Expenditures, 1 Yr. Growth %	99.15	-63.65	366.13	30.06	-93.56
Levered Free Cash Flow, 1 Yr. Growth %	643.07	-104.1	-1.78K	-294.46	-185.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-491	-133.78	-604.45	-356.82	-146.28
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-18.23	-8.36	-2.05	16.64	9.03
Gross Profit, 2 Yr. CAGR %	-22.5	-12.32	2.43	35.65	3.17
EBITDA, 2 Yr. CAGR %	-77.82	-69.23	278.79	350.62	3.15
EBITA, 2 Yr. CAGR %	-40.69	68.07	34.17	29.34	-4.46
EBIT, 2 Yr. CAGR %	24.45	39.43	-54.01	-86.82	-13.72
Earnings From Cont. Operations, 2 Yr. CAGR %	-35.49	0.53	-21.91	-20.68	-9.47
Net Income, 2 Yr. CAGR %	-35.08	1.45	-22.41	-20.92	-9.24
Normalized Net Income, 2 Yr. CAGR %	14.1	-23.76	-89.87	3.28	322.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.78	-8.48	-37.11	-25.11	-16.37
Accounts Receivable, 2 Yr. CAGR %	-10.86	-15.26	-2.61	19.37	-5.09
Inventory, 2 Yr. CAGR %	1.35	3.97	7.83	3.55	1.19
Net Property, Plant and Equip., 2 Yr. CAGR %	14.52	-2.28	-4.68	17.93	7.99
Total Assets, 2 Yr. CAGR %	13.91	-19.72	-8.59	13.49	5.63
Tangible Book Value, 2 Yr. CAGR %	-0.01	0.89	4.32	3.15	5.36
Common Equity, 2 Yr. CAGR %	-2.39	-4.03	-1	-0.77	1.92
Cash From Operations, 2 Yr. CAGR %	-73.26	-13.59	77.89	-23.69	21.19
Capital Expenditures, 2 Yr. CAGR %	53.46	-14.91	30.17	146.22	-71.06
Levered Free Cash Flow, 2 Yr. CAGR %	98.25	-44.83	-16.95	472.28	29.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	-3.41	14.93	30.55	259.94	9.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-13.12	-21.07	3.09	0.02	15.75
Gross Profit, 3 Yr. CAGR %	-0.87	-28.3	9.53	4.15	22.07
EBITDA, 3 Yr. CAGR %	-58.94	-69.06	31.19	130.32	193.84
EBITA, 3 Yr. CAGR %	-33.07	-35.71	88.83	8.1	29.58
EBIT, 3 Yr. CAGR %	-21.3	11.31	-22.7	-75.09	-43.87
Earnings From Cont. Operations, 3 Yr. CAGR %	14.66	-8.49	-30.57	5.02	-35.25
Net Income, 3 Yr. CAGR %	18.86	-8.43	-30.2	4.45	-35.19
Normalized Net Income, 3 Yr. CAGR %	15.85	9.51	-81.92	2.47	-43.36
Diluted EPS Before Extra, 3 Yr. CAGR %	13.13	-15.98	-39.98	-4.96	-43.46
Accounts Receivable, 3 Yr. CAGR %	-8.49	-19.86	1.69	-2.64	9.68
Inventory, 3 Yr. CAGR %	-1.42	3.33	5.37	4.82	3.49
Net Property, Plant and Equip., 3 Yr. CAGR %	11.96	4.19	0.2	6.25	7.11
Total Assets, 3 Yr. CAGR %	-2.59	-2.71	-8.79	-2.95	9.52
Tangible Book Value, 3 Yr. CAGR %	-10.08	-7.61	11.99	-5.68	15.27
Common Equity, 3 Yr. CAGR %	-11.55	-9.06	4.58	-8.06	8.85
Cash From Operations, 3 Yr. CAGR %	-66.16	-25.26	-26.02	50.36	-7.31
Capital Expenditures, 3 Yr. CAGR %	-5.22	-5.05	50	30.14	-26.92
Levered Free Cash Flow, 3 Yr. CAGR %	-5.14	-45.6	72.42	10.29	204.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	-20.78	-31.94	88.18	63.58	81.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.87	-7.52	-8.85	-7.72	5.43
Gross Profit, 5 Yr. CAGR %	27.27	5.08	0.43	-7.47	6.94
EBITDA, 5 Yr. CAGR %	-45.83	-53.94	-0.13	-9.67	19.16
EBITA, 5 Yr. CAGR %	-26.04	-34.45	-11.6	-14.97	43.79
EBIT, 5 Yr. CAGR %	-12.92	-20.39	-36.51	-52.59	-19.23
Earnings From Cont. Operations, 5 Yr. CAGR %	28.33	15.53	-1.67	-13.58	-22.79
Net Income, 5 Yr. CAGR %	40.37	20.68	0.22	-13.65	-22.47
Normalized Net Income, 5 Yr. CAGR %	47.43	17.29	-56.29	6.97	-36.21
Diluted EPS Before Extra, 5 Yr. CAGR %	26.82	11.06	-10.55	-19.77	-31.46
Accounts Receivable, 5 Yr. CAGR %	-3.8	-8.97	-6.18	-6.02	-1.08
Inventory, 5 Yr. CAGR %	1.8	6.02	2.18	3.42	3.68
Net Property, Plant and Equip., 5 Yr. CAGR %	5.42	-12.99	4.98	9.48	3.25
Total Assets, 5 Yr. CAGR %	7.24	-10.67	-5.03	3.47	-3.28
Tangible Book Value, 5 Yr. CAGR %	18.65	8.31	-4.57	-3.45	9.29
Common Equity, 5 Yr. CAGR %	10.44	-4.82	-7.47	-5.83	3.5
Cash From Operations, 5 Yr. CAGR %	-40.84	-26.67	-34.27	-24.63	-9.88
Capital Expenditures, 5 Yr. CAGR %	-1.82	-40.11	7.61	39.01	-22.34
Levered Free Cash Flow, 5 Yr. CAGR %	-5.47	-64.01	-10.05	39.44	53.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	-21.21	-54.49	-3.26	32.5	51.27